EMMA-1 (Erbitux for Multiple Myeloma)

Clinical trial NCT00368121 · TERMINATED

Trial details

NCT number: NCT00368121
Sponsor: Prof. Dr. Andreas Engert
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2006-08-01
Primary completion: 2012-06-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.